Arcosa Inc. (ACA)

The healthcare company also struck a deal with Novo Nordisk to sell Wegovy at a reduced price for cash-paying customers through its pharmacies.

DALLAS--(BUSINESS WIRE)--Arcosa, Inc. (NYSE: ACA) (“Arcosa” or the “Company”), a provider of infrastructure-related products and solutions, today announced that it will release results for the first q...

AAL, ACA and BLKB have been added to the Zacks Rank #5 (Strong Sell) List on April 15, 2025.

Investors need to pay close attention to Arcosa (ACA) stock based on the movements in the options market lately.

ASTS, AMPY and ACA have been added to the Zacks Rank #5 (Strong Sell) List on April 7, 2025.

ACA's topline grew 14.4% YoY in Q4 2024, driven by strong pricing and recent acquisitions, despite a 14% decline in Transportation Products revenue. Expect continued growth in 2025, fueled by strong i...

Arcosa, Inc. (NYSE:ACA ) Q4 2024 Earnings Conference Call February 28, 2025 8:30 AM ET Company Participants Erin Drabek - Vice President of Investor Relations Antonio Carrillo - President and CEO Gail...

Arcosa (ACA) came out with quarterly earnings of $0.46 per share, missing the Zacks Consensus Estimate of $0.79 per share. This compares to earnings of $0.68 per share a year ago.

DALLAS--(BUSINESS WIRE)--Arcosa, Inc. (NYSE: ACA) (“Arcosa,” the “Company,” “We,” or “Our”), a provider of infrastructure-related products and solutions, today announced results for the fourth quarter...

DALLAS--(BUSINESS WIRE)--Arcosa, Inc. (NYSE: ACA) (“Arcosa” or the “Company”), a provider of infrastructure-related products and solutions, today announced that its Board of Directors has declared a r...